Methods: A cross-sectional study included 160 patients with

liver cirrhosis admitted to The Liver Units in Zagazig University Hospitals from July 2012 to December 2012 with history of follow up in outpatient’s clinics. Patients were classified into three groups: I) 42 non ascetic patients II) 50 ascetic patients without renal impairment, and III) 68 ascetic patients with renal impairment. Patients with renal impairment was further divided into four subgroups: [A] pre-renal azotemia; [B] Chronic kidney disease (CKD); [C] HRS; and [D] ATN. Results: Significant elevations of both Urinary NGAL and Urinary IL-18 in cirrhotic patients with renal impairment especially in patients with acute tubular necrosis (ATN) were observed. AUROC was (0.909) with (sensitivity 95.5 %, specificity 76.1) for Urinary NGAL and AUROC was (0.975), with (sensitivity 95.5 %, specificity 91.3 %) for Urinary

IL-18 as selleck chemicals early biomarkers of acute kidney injury in cirrhotic patients. Conclusion: Urinary NGAL and urinary IL-18 have the ability to early detection and differentiation AKI types in patients with cirrhosis. This could improve risk stratification for patients admitted to the hospital with cirrhosis, perhaps leading to early ICU admission, transplant evaluation, and prompt early initiation of AKI management especially HRS. MORITO TAKU1,2, ANDO MINORU1, NOKIBA HIROHIKO1, HARA MASAKI1, TSUCHIYA KEN2, NITTA KOSAKU2 1Renal Division, Department of Medicine, Tokyo Metropolitan Cancer Center,

Komagome Hospital, Japan; 2Department IV of Internal Buspirone HCl Medicine, Tokyo Women’s PLX4032 chemical structure Medical University, Japan Introduction: AKI that occurs before the stem-cell engraftment may be fatal in allogeneic hematopoietic stem cell transplantation (SCT). Prediction of such AKI may contribute to the improvement of prognosis in SCT recipients. Methods: One-year prospective cohort study was conducted in 94 allogeneic SCT recipients, who had normal kidney function at baseline. Urinary Liver-type fatty acid binding protein (L-FABP) level was measured as a marker of tubular damage before conditioning therapy (baseline), and at days 0 (the morning of SCT). The “AKI prior to the stem-cell engraftment” was defined as the “early AKI” and the subsequently-occurred AKI was as the “late AKI”. Cumulative mortality was analyzed by the Kaplan–Meier method. Multivariate Cox hazards analysis was used to ascertain an association between the “early AKI” and the mortality. Discriminative ability of L-FABP for emergence of the early AKI was evaluated by AUC-ROC. Results: The early and late AKI developed in 23 patients (24.5%) and 41 patients (43.6%), respectively. The cumulative mortality of patients with the early AKI was the highest among the 3 groups: 73.9% in the early AKI; 24.7% in the late AKI; and 21.2% in the non-AKI.